• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Acessa Health launches third-gen Acessa ProVu system

Acessa Health launches third-gen Acessa ProVu system

November 2, 2018 By Fink Densford

Acessa Health

Acessa Health said today that it launched its third-generation Acessa ProVu system intended to treat uterine fibroid tumors with minimally-invasive laparoscopic radiofrequency ablation in the U.S.

The Austin, Texas-based company added that the system has been used in its first procedures in the U.S.

“I’ve used every generation of the Acessa family of products and can say, with certainty, that after using Acessa ProVu, the system has reached a pinnacle of technological innovation. The Acessa ProVu system is going to allow more physicians to offer this treatment to their patients and I’m excited to be part of the movement changing how gynecologists approach the treatment of fibroids,” Dr. Carlos Quezada of the San Antonio, Texas-based Christus Health said in a prepared statement.

Acessa Health said that a 10-year systemic review of uterine-preserving hysterectomy alternatives indicated that Acessa’s laparsocopic radiofrequency ablation procedure was associated with low complication rates, minimal blood loss and low rates of re-intervention.

Patients also reported major quality of life improvements and improved symptom severity scores compared to traditional interventions.

“Our organization shares the widespread enthusiasm that Dr. Garza refers to when we look at our uterine fibroid business here at Acessa. This excitement has led to dramatic demand for Acessa over the last several months. The initial feedback on Acessa ProVu is tremendously encouraging and we feel well-positioned to serve our physicians and their patients who suffer from symptomatic fibroids,” prez & CEO Kim Rodriguez said in a press release.

The company won FDA 510(k) clearance from the device early last month, with indications for treating symptomatic uterine fibroids.

Filed Under: Business/Financial News, Featured Tagged With: acessahealth

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy